Diabetes Is Not For The Faint Of Heart
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Regulatory and commercial hurdles in the type 2 diabetes market have created a space where only the largest, most sophisticated companies can expect to compete.